| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
64,660 |
53,884 |
$9.79M |
| 0761 |
|
21,132 |
20,235 |
$780K |
| 0250 |
|
70,219 |
25,973 |
$321K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,847 |
2,699 |
$301K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,125 |
1,913 |
$239K |
| 0370 |
|
515 |
493 |
$228K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,486 |
2,343 |
$215K |
| 0360 |
|
1,609 |
1,041 |
$192K |
| 0002A |
|
4,412 |
4,412 |
$176K |
| 0001A |
|
4,405 |
4,405 |
$171K |
| Z7502 |
|
3,636 |
3,603 |
$136K |
| 0510 |
|
3,684 |
3,610 |
$97K |
| 0301 |
|
58,208 |
21,594 |
$86K |
| A4649 |
Surgical supply; miscellaneous |
1,880 |
564 |
$73K |
| 0762 |
|
382 |
302 |
$68K |
| 0483 |
|
336 |
318 |
$51K |
| 96379 |
|
1,761 |
700 |
$40K |
| 80053 |
Comprehensive metabolic panel |
9,420 |
8,721 |
$39K |
| 0710 |
|
1,580 |
1,194 |
$36K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
759 |
690 |
$36K |
| 0480 |
|
419 |
213 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,451 |
1,354 |
$31K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
299 |
295 |
$29K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
872 |
812 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,528 |
8,886 |
$29K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
148 |
142 |
$23K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
575 |
511 |
$17K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
591 |
511 |
$16K |
| 0403 |
|
154 |
154 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,683 |
1,552 |
$14K |
| 93325 |
|
149 |
142 |
$13K |
| 0305 |
|
17,424 |
12,433 |
$11K |
| 93320 |
|
143 |
137 |
$10K |
| 0272 |
|
508 |
496 |
$7K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
299 |
295 |
$7K |
| 99070 |
|
12,552 |
6,812 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
349 |
332 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
355 |
345 |
$7K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
129 |
125 |
$6K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
105 |
94 |
$6K |
| Z7500 |
|
148 |
121 |
$5K |
| 0740 |
|
73 |
70 |
$5K |
| J3490 |
Unclassified drugs |
273 |
126 |
$5K |
| 82077 |
|
168 |
156 |
$5K |
| 0921 |
|
209 |
164 |
$5K |
| 0420 |
|
102 |
27 |
$4K |
| 59025 |
Fetal non-stress test |
188 |
135 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
108 |
102 |
$4K |
| G0378 |
Hospital observation service, per hour |
148 |
138 |
$4K |
| 0730 |
|
1,054 |
1,034 |
$3K |
| 0611 |
|
12 |
12 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
465 |
417 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
135 |
130 |
$3K |
| 95812 |
|
46 |
43 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
386 |
354 |
$3K |
| 96150 |
|
398 |
340 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
656 |
627 |
$3K |
| 0750 |
|
21 |
14 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
67 |
56 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
292 |
257 |
$2K |
| 0320 |
|
3,111 |
2,658 |
$2K |
| Z7514 |
|
32 |
26 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
519 |
497 |
$2K |
| 0260 |
|
1,714 |
902 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
227 |
226 |
$2K |
| 84484 |
|
862 |
717 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
174 |
157 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
173 |
172 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
18 |
17 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
848 |
668 |
$1K |
| 83690 |
|
655 |
617 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
43 |
$1K |
| 82805 |
|
227 |
193 |
$996.72 |
| 81003 |
|
798 |
709 |
$980.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
905 |
855 |
$962.40 |
| 0003A |
|
24 |
24 |
$960.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
230 |
177 |
$835.31 |
| 0307 |
|
691 |
585 |
$802.84 |
| 0011A |
|
41 |
41 |
$694.54 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
542 |
527 |
$666.20 |
| 85027 |
|
306 |
254 |
$606.60 |
| 0258 |
|
444 |
362 |
$563.55 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$534.66 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
607 |
585 |
$527.83 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$482.28 |
| Z7610 |
|
381 |
185 |
$463.61 |
| 83735 |
|
132 |
92 |
$433.06 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
558 |
510 |
$418.42 |
| 0760 |
|
12 |
12 |
$409.20 |
| 82375 |
|
227 |
193 |
$399.85 |
| 83605 |
|
214 |
179 |
$380.85 |
| 81001 |
|
605 |
585 |
$370.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
241 |
230 |
$364.17 |
| 82947 |
|
543 |
375 |
$336.98 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
59 |
55 |
$332.62 |
| 0270 |
|
37 |
25 |
$300.07 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
62 |
62 |
$272.25 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
194 |
187 |
$270.07 |
| 99152 |
|
54 |
52 |
$251.36 |
| 85007 |
|
154 |
121 |
$243.64 |
| 84703 |
|
79 |
71 |
$221.82 |
| 83615 |
|
51 |
27 |
$218.91 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
826 |
292 |
$217.05 |
| 85610 |
|
322 |
303 |
$203.19 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
14 |
$203.18 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
212 |
159 |
$202.89 |
| 83880 |
|
42 |
39 |
$183.08 |
| 84100 |
|
52 |
27 |
$174.73 |
| C1769 |
Guide wire |
14 |
14 |
$168.51 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
134 |
114 |
$151.98 |
| 86140 |
|
182 |
175 |
$150.27 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
56 |
40 |
$133.66 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
25 |
$132.71 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
44 |
44 |
$126.13 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
13 |
$125.00 |
| 80047 |
|
93 |
86 |
$107.52 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
195 |
85 |
$99.35 |
| 87040 |
|
68 |
44 |
$67.11 |
| 80076 |
|
26 |
25 |
$61.69 |
| 87077 |
|
73 |
64 |
$58.66 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
66 |
66 |
$47.89 |
| 36600 |
|
12 |
12 |
$44.05 |
| 85379 |
|
13 |
13 |
$32.50 |
| 80069 |
|
12 |
12 |
$30.40 |
| 86901 |
|
36 |
36 |
$25.07 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
44 |
42 |
$24.99 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
12 |
12 |
$24.24 |
| 86850 |
|
12 |
12 |
$23.00 |
| 0306 |
|
371 |
188 |
$21.60 |
| 86900 |
|
24 |
24 |
$11.80 |
| 87186 |
|
12 |
12 |
$6.06 |
| J2060 |
Injection, lorazepam, 2 mg |
13 |
12 |
$4.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
27 |
27 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
90 |
84 |
$0.00 |
| 0302 |
|
28 |
13 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
34 |
15 |
$0.00 |
| 0352 |
|
29 |
24 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
32 |
12 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
54 |
38 |
$0.00 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
30 |
12 |
$0.00 |